Colesevelam Hydrochloride Tablet
FDA Label NDC 51407-336

37 label sections · Submitted to the FDA by Golden State Medical Supply, Inc. · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Golden State Medical Supply, Inc. for the product Colesevelam Hydrochloride (NDC 51407-336). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding 1 indications and usage, 1.1 primary hyperlipidemia, 1.2 type 2 diabetes mellitus, 1.3 limitations of use, 2.1 testing prior to initiation of colesevelam hydrochloride tablets, 2.2 recommended dosage in primary hyperlipidemia and type 2 diabetes mellitus, 2.3 important dosing information for primary hyperlipidemia, 2.4 administration instructions, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

* Please review the disclaimer below.